학술논문
Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study
Document Type
Article
Author
Source
In Gynecologic Oncology December 2019 155(3):420-428
Subject
Language
ISSN
0090-8258